Randomized phase III study of high-dose methotrexate and whole brain radiotherapy with or without concomitant and adjuvant temozolomide in patients with newly diagnosed primary central nervous system lymphoma: JCOG1114C.
Kazuhiko Mishima, Haruhiko Fukuda(National Cancer Center Hospital East), Yasutomo Momii(Oita University), Hikaru Sasaki(Tokyo Dental College Ichikawa General Hospital), Ryo Nishikawa(Kanazawa Hospital), Naoki Shinojima, Minako Sumi(Tokyo Metropolitan Geriatric Hospital), Junki Mizusawa(Japan Clinical Cancer Research Organization), Atsushi Sasaki(Saitama Medical University), Kenichiro Asano(Hirosaki University), Yoshiki Arakawa(Kyoto Prefectural University of Medicine), Koji Yoshimoto(Kyushu University), Takao Tsurubuchi(University of Tsukuba), Akio Asai(Kansai Medical University), Ichiyo Shibahara(Kitasato University), Motoo Nagane(Kyorin University), Manabu Kinoshita(Brigham and Women's Hospital), Hiroshi Katayama(National Cancer Center), Yoshitaka Narita(Unknown), Takashi Sasayama(Himeji Medical Center)
Cited by 9
Related Papers
Segmentectomy versus lobectomy in small-sized peripheral non-small-cell lung cancer (JCOG0802/WJOG4607L): a multicentre, open-label, phase 3, randomised, controlled, non-inferiority trial
|The Lancet|2022|1.6k
Molecular Determinants of the Response of Glioblastomas to EGFR Kinase Inhibitors
|New England Journal of Medicine|2005|1.4k
Aberrant CpG-island methylation has non-random and tumour-type–specific patterns
|Nature Genetics|2000|1.4k
A Prospective Radiological Study of Thin-Section Computed Tomography to Predict Pathological Noninvasiveness in Peripheral Clinical IA Lung Cancer (Japan Clinical Oncology Group 0201)
|Journal of Thoracic Oncology|2011|656
Noninvasive localized delivery of Herceptin to the mouse brain by MRI-guided focused ultrasound-induced blood–brain barrier disruption
|Proceedings of the National Academy of Sciences|2006|648